Show simple item record

dc.contributor.authorJohnson, M. B.
dc.date.accessioned2021-03-23T14:37:40Z
dc.date.available2021-03-23T14:37:40Z
dc.date.issued2020-11
dc.identifier.citationWegehaupt O et al. Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient. J Clin Immunol. 2020 Nov;40(8):1207-1210. doi: 10.1007/s10875-020-00864-w. Epub 2020 Sep 17.en_US
dc.identifier.pmid32944850
dc.identifier.doi10.1007/s10875-020-00864-w
dc.identifier.urihttps://rde.dspace-express.com/handle/11287/621683
dc.description.abstractThis article is available to RD&E staff via NHS OpenAthens. Click on the Publisher URL, and log in with NHS OpenAthens if prompted.en_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.urlhttps://doi.org/10.1007/s10875-020-00864-wen_US
dc.rightsCopyright © 2020, The Author(s) Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en_US
dc.rightsCC0 1.0 Universal*
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.subjectRuxolitiniben_US
dc.subjectLymphoproliferationen_US
dc.subjectDiabetesen_US
dc.subjectSTAT3-GOFen_US
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen_US
dc.titleRuxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patienten_US
dc.typeLetteren_US
dc.identifier.journalJournal of Clinical Immunologyen_US
dc.identifier.pmcidPMC7567728
dc.type.versionPublisheden_US
dc.description.admin-notepublished version, accepted version (12 month embargo)en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Copyright © 2020, The Author(s)
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's license is described as Copyright © 2020, The Author(s) Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.